Back to mobile site

TD Cowen on Boston Scientific (BSX): 'Cyberattack To Weigh on Q3 Results; We Remain Bullish on the Setup for 2027'

October 20, 2026 9:14 AM EDT Send to a Friend
TD Cowen analyst Joshua Jennings reiterated a Buy rating and $56.00 price target on Boston Scientific (NYSE: BSX).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login